Apixaban, an oral direct factor Xa inhibitor, inhibits human clot-bound factor Xa activity in vitro

被引：71
|
作者：
Jiang, Xiaosui [1 ]
Crain, Earl J. [1 ]
Luettgen, Joseph M. [1 ]
Schumacher, William A. [1 ]
Wong, Pancras C. [1 ]
机构：
[1] Bristol Myers Squibb Co, Thrombosis Res, Pennington, NJ 08534 USA
来源：
THROMBOSIS AND HAEMOSTASIS | 2009年 / 101卷 / 04期
关键词：
PROCOAGULANT ACTIVITY; HEPARIN-ANTITHROMBIN; BLOOD-COAGULATION; THROMBOSIS; EFFICACY; INACTIVATION; SAFETY;
D O I：
10.1160/TH08-07-0486
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：780 / 782
页数：3
相关论文
共 50 条
  • [41] Effect of the Direct Factor Xa Inhibitor Apixaban in Rat Models of Thrombosis and Hemostasis
    Schumacher, William A.
    Bostwick, Jeffrey S.
    Stewart, Anne B.
    Steinbacher, Thomas E.
    Xin, Baomin
    Wong, Pancras C.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2010, 55 (06) : 609 - 616
  • [42] EFFECT OF BODY WEIGHT ON THE PHARMACOKINETICS OF APIXABAN, AN ORAL DIRECT FACTOR Xa INHIBITOR, IN HEALTHY SUBJECTS.
    Upreti, Vijay V.
    Wang, Jessie
    Barrett, Yuchen
    Boyd, Rebecca
    Bui, Anh
    Li, Tong
    LaCreta, Frank P.
    Frost, Charles E.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1060 - 1060
  • [43] Rivaroxaban: An Oral Factor Xa Inhibitor
    Thomas, Tyan F.
    Ganetsky, Valerie
    Spinier, Sarah A.
    CLINICAL THERAPEUTICS, 2013, 35 (01) : 4 - 27
  • [44] Rivaroxaban An Oral Direct Factor Xa Inhibitor for the Prevention of Thromboembolism
    Chen, Terry
    Lam, Sum
    CARDIOLOGY IN REVIEW, 2009, 17 (04) : 192 - 197
  • [45] The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor
    Perzborn, Elisabeth
    Roehrig, Susanne
    Straub, Alexander
    Kubitza, Dagmar
    Misselwitz, Frank
    NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (01) : 61 - +
  • [46] The direct factor Xa inhibitor rivaroxaban
    Verma, Abhishek K.
    Brighton, Timothy A.
    MEDICAL JOURNAL OF AUSTRALIA, 2009, 190 (07) : 379 - 383
  • [47] The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor
    Elisabeth Perzborn
    Susanne Roehrig
    Alexander Straub
    Dagmar Kubitza
    Frank Misselwitz
    Nature Reviews Drug Discovery, 2011, 10 : 61 - 75
  • [48] Edoxaban: An Update on the New Oral Direct Factor Xa Inhibitor
    Henri Bounameaux
    A. John Camm
    Drugs, 2014, 74 : 1209 - 1231
  • [49] Pharmacokinetics and Pharmacodynamics of Rivaroxaban - An Oral, Direct Factor Xa Inhibitor
    Kreutz, Reinhold
    CURRENT CLINICAL PHARMACOLOGY, 2014, 9 (01): : 75 - 83
  • [50] Edoxaban: An Update on the New Oral Direct Factor Xa Inhibitor
    Bounameaux, Henri
    Camm, A. John
    DRUGS, 2014, 74 (11) : 1209 - 1231
12345